tirzepatide efectos secundarios en mujeres de la Tirzepatida EFICACIA Y SEGURIDAD DE TIRZEPATIDA

Among the 4,076 participants, 80% were receiving ACE inhibitors, ARBs, or angiotensin receptor-neprilysin inhibitors, and 15.2% were on SGLT2 inhibitors

Purinergic Signal 2020;16:167174.ArticlePubMedPMC 5

doi: 10.3389/fnut.2025.1539665 Received 04 December 2024 Accepted 21 February 2025 Published 12 March 2025 Volume 12 - 2025 Edited by Maria Luisa Mizgier, University of the Andes, Chile Reviewed by Magorzata Mizgier, Poznan University of Physical Education, Poland Marija Stojanovic, University of Belgrade, Serbia Updates Copyright 2025 Zhou, Liu, Jian, Jiang and Liu

The inflammation gradually spreads to the joints between the vertebrae, eventually involving the whole spine, causing a condition called spondylitis